A Controlled Clinical Study to Evaluate a Proprietary Non-Invasive Smartphone Based Digital Biomarker Tool Lyfas® in Enabling Early Detection of COVID-19 Infection Among Asymptomatic Individuals (original) (raw)

International journal of scientific research, 2021

Abstract

Coronavirus disease 2019 (COVID-19), is a pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). With the increasing number of individuals infected with COVID-19, there is a growing need for easy, dependable, accurate, scalable, and cost-effective tools. These tools should serve the purpose of population screening/surveillance, diagnosis, and prognosis. Unlike the other pandemics in the past, the current viral infection presents itself with long incubation period up to 14days. This situation is challenging because it results in an extremely high proportion of asymptomatic individuals (up to 80% and more). These individuals in turn contribute to high risk of transmission among the vulnerable population with coexisting diseases and the aged. Currently, the real time PCR test and serology is being largely employed only in symptomatic individuals. Therefore, there is a need for a dependable additional test to identify the asymptomatic individuals, to qualify th...

Dr. Geetha Mahadevappa hasn't uploaded this paper.

Let Dr. Geetha know you want this paper to be uploaded.

Ask for this paper to be uploaded.